causaLens
PrivateLast Round
Series A
Jan 27, 2022
Est. Valuation
$250M
Total Funding Raised
$50M
Momentum Score
50 /100
Company Overview
CausaLens is a technology company that creates autonomous predictive applications to enhance human-centered decision-making through big data analytics.
Sector
AI, Data & Cloud Infrastructure
Verticals
ML Platforms, Business Intelligence, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
causaLens Comps
Public and private peers based on sector, stage, and business model.
causaLens Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 27, 2022 | ||||
| Seed | Apr 18, 2019 |
Key People
Founding team and executive leadership
causaLens Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Generation Ventures | Series A, Seed |
| Dorilton Ventures | Series A |
| LetterOne | Series A |
| Dorilton | Series A |
| IQ Capital | Seed, Series A |
| Dorilton Ventures | Series A |
| Generation Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
IPG Group referenced as a new customer.
- Mar 1, 2026
Johnson & Johnson, Syneos Health, and Cisco referenced as clients.
causaLens Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about causaLens's valuation, stock price, and market status.
